229 related articles for article (PubMed ID: 22361454)
1. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer.
Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM
Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454
[TBL] [Abstract][Full Text] [Related]
2. 5α-reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives.
Al-Mohizea AM; Al-Omar MA; Abdalla MM; Amr AG
Int J Biol Macromol; 2012 Jan; 50(1):171-9. PubMed ID: 22057085
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of novel 16-imidazolyl substituted steroidal derivatives possessing potent diversified pharmacological properties.
Bansal R; Guleria S; Thota S; Bodhankar SL; Patwardhan MR; Zimmer C; Hartmann RW; Harvey AL
Steroids; 2012 May; 77(6):621-9. PubMed ID: 22366075
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Structure-Activity Relationships of Tetrahydro-β-carboline Derivatives as Anticancer and Cancer-chemopreventive Agents.
Zhang M; Park EJ; Kondratyuk TP; Pezzuto JM; Sun D
Anticancer Res; 2018 Aug; 38(8):4425-4433. PubMed ID: 30061206
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1.
Prior AM; Yu X; Park EJ; Kondratyuk TP; Lin Y; Pezzuto JM; Sun D
Bioorg Med Chem Lett; 2017 Dec; 27(24):5393-5399. PubMed ID: 29153737
[TBL] [Abstract][Full Text] [Related]
6. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.
Dai Y; Wang Q; Zhang X; Jia S; Zheng H; Feng D; Yu P
Eur J Med Chem; 2010 Dec; 45(12):5612-20. PubMed ID: 20926163
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
Ahmad I; Shagufta
Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
Sun B; Hoshino J; Jermihov K; Marler L; Pezzuto JM; Mesecar AD; Cushman M
Bioorg Med Chem; 2010 Jul; 18(14):5352-66. PubMed ID: 20558073
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles.
Banday AH; Saeed BA; Al-Masoudi NA
Anticancer Agents Med Chem; 2021; 21(13):1671-1679. PubMed ID: 33238853
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives.
Gasi KM; Brenesel MDj; Djurendić EA; Sakac MN; Canadi JJ; Daljev JJ; Armbruster T; Andrić S; Sladić DM; Bozić TT; Novaković IT; Juranić ZD
Steroids; 2007 Jan; 72(1):31-40. PubMed ID: 17118415
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
Bubert C; Woo LW; Sutcliffe OB; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2008 Nov; 3(11):1708-30. PubMed ID: 18816537
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells.
Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY
Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents.
Jindal DP; Bedi V; Jit B; Karkra N; Guleria S; Bansal R; Palusczak A; Hartmann RW
Farmaco; 2005 Apr; 60(4):283-90. PubMed ID: 15848202
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids.
Bansal R; Thota S; Karkra N; Minu M; Zimmer C; Hartmann RW
Bioorg Chem; 2012 Dec; 45():36-40. PubMed ID: 23064126
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory profile of some synthesized heterocyclic pyridone and pyridine derivatives fused with steroidal structure.
Amr AG; Abdulla MM
Bioorg Med Chem; 2006 Jul; 14(13):4341-52. PubMed ID: 16545570
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antineoplastic activity of O-alkylated derivatives of 7-hydroximinoandrost-5-ene steroids.
Bansal R; Guleria S; Ries C; Hartmann RW
Arch Pharm (Weinheim); 2010 Jul; 343(7):377-83. PubMed ID: 20309873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
